Guide to Quality Drug Data:
Discover the critical elements of quality drug data & how to strengthen yours.
Discover the critical elements of quality drug data and learn how to strengthen yours.
Learn More!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Refractory Solid Tumors
Also known as:
Refractory Solid Tumor
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB17569
2-O, 3-O desulfated heparin
1
Terminated
1
DB00112
Bevacizumab
1
Completed
1
DB08889
Carfilzomib
1
Completed
1
DB00002
Cetuximab
1
Completed
1
DB00531
Cyclophosphamide
1
Completed
2
DB01254
Dasatinib
1
Terminated
1
DB08871
Eribulin
1
Completed
1
DB00530
Erlotinib
1
Completed
1
DB00773
Etoposide
1
Completed
1
DB00544
Fluorouracil
1
Completed
1
DB00441
Gemcitabine
1
Terminated
1
DB00762
Irinotecan
1
Completed
4
DB09078
Lenvatinib
1
Completed
1
DB00650
Leucovorin
1
Completed
1
DB13982
Lutetium Lu-177
1
Recruiting
2
DB00179
Masoprocol
1
Terminated
1
DB00218
Moxifloxacin
1
Completed
1
DB00398
Sorafenib
1
Completed
2
DB08937
TAS-102
1
Completed
1
DB12226
Terameprocol
1
Terminated
1
DB05585
Verubulin
1
Completed
1
DB12001
Abemaciclib
1 / 2
Recruiting
1
DB11595
Atezolizumab
1 / 2
Recruiting
1
DB00112
Bevacizumab
1 / 2
Recruiting
1
DB14707
Cemiplimab
1 / 2
Terminated
1
DB00531
Cyclophosphamide
1 / 2
Recruiting
1
DB09077
Dinutuximab
1 / 2
Recruiting
1
DB08871
Eribulin
1 / 2
Recruiting
1
DB00762
Irinotecan
1 / 2
Recruiting
2
DB00398
Sorafenib
1 / 2
Recruiting
1
DB00853
Temozolomide
1 / 2
Recruiting
2
DB01169
Arsenic trioxide
2
Recruiting
1
DB01275
Hydralazine
2
Completed
1
DB00526
Oxaliplatin
2
Unknown Status
1
DB00313
Valproic acid
2
Completed
1
DB00877
Sirolimus
4
Completed
1
DB01268
Sunitinib
4
Completed
1
DB06589
Pazopanib
Not Available
Completed
2
DB00398
Sorafenib
Not Available
Completed
1
DB00398
Sorafenib
Not Available
Withdrawn
1
DB01268
Sunitinib
Not Available
Completed
1